Bifunctional-modified hydrogels
Disclosed are hydrogels wherein a polymer matrix is modified to contain a bifunctional poly(alkylene glycol) molecule covalently bonded to the polymer matrix. The hydrogels can be cross-linked using, for example, glutaraldehyde. The hydrogels may also be crosslinked via an interpenetrating network of a photopolymerizable acrylates. The hydrogels may also be modified to have pharmacologically-active agents covalently bonded to the poly(alkylene glycol) molecules or entrained within the hydrogel. Living cells may also be entrained within the hydrogels.
1. A hydrogel comprising:
a first polymer matrix containing reactive amino moieties;
a heterobifunctional modifier comprising a compound of formula:
wherein at least one of the “A” or “Z” moieties is covalently bonded to the reactive amino moieties of the first polymer matrix; and wherein “A” and “Z” are independently a monovalent or divalent organic moiety; wherein at least one of A and Z is a divalent moiety; if A or Z is a monovalent moiety, then A or Z is selected from the group consisting of halo, hydroxy, C 1 -C 24 -alkyl, C 1 -C 24 -alkenyl, C 1 -C 24 -alkynyl, C 1 -C 24 -alkoxy, C 1 -C 24 -heteroalkyl, C 1 -C 24 -heteroalkenyl, C 1 -C 24 -heteroalkynyl, cyano-C 1 -C 24 -alkyl, a C 3 -C 10 -cycloalkyl, C 3 -C 10 -cycloalkenyl, C 3 -C 10 -cycloalkynyl, C 3 -C 10 -cycloheteroalkyl, C 3 -C 10 -cycloheteroalkenyl, C 3 -C 10 -cycloheteroalkynyl, acyl, acyl-C 1 -C 24 -alkyl, acyl-C 1 -C 24 -alkenyl, acyl-C 1 -C 24 -alkynyl, carboxy, C 1 -C 24 -alkylcarboxy, C 1 -C 24 -alkenylcarboxy, C 1 -C 24 -alkynylcarboxy, carboxy-C 1 -C 24 -alkyl, carboxy-C 1 -C 24 -alkenyl, carboxy-C 1 -C 24 -alkynyl, aryl, aryl-C 1 -C 24 -alkyl, aryl-C 1 -C 24 -alkenyl, aryl-C 1 -C 24 -alkynyl, heteroaryl, heteroaryl-C 1 -C 24 -alkyl, heteroaryl-C 1 -C 24 -alkenyl, heteroaryl-C 1 -C 24 -alkynyl, sulfonate, arylsulfonate, and heteroarylsulfonate;
if A or Z is a divalent moiety, then A or Z is independently selected from a divalent equivalent of a monovalent moiety selected from the group consisting of C 1 -C 24 -alkyl, C 1 -C 24 -alkenyl C 1 -C 24 -alkynyl, C 1 -C 24 -alkoxy, C 1 -C 24 -heteroalkyl, C 1 -C 24 -heteroalkenyl, C 1 -C 24 -heteroalkynyl, cyano-C 1 -C 24 -alkyl, a C 3 -C 10 -cycloalkyl, C 3 -C 10 -cycloalkenyl, C 3 -C 10 -cycloalkynyl, C 3 -C 10 -cycloheteroalkyl, C 3 -C 10 -cycloheteroalkenyl, C 3 -C 10 -cycloheteroalkynyl, acyl, acyl-C 1 -C 24 -alkyl, acyl-C 1 -C 24 -alkenyl, acyl-C 1 -C 24 -alkynyl, carboxy, C 1 -C 24 -alkylcarboxy, C 1 -C 24 -alkenylcarboxy, C 1 -C 24 -alkynylcarboxy, carboxy-C 1 -C 24 -alkyl, carboxy-C 1 -C 24 -alkenyl, carboxy-C 1 -C 24 -alkynyl, aryl, aryl-C 1 -C 24 -alkyl, aryl-C 1 -C 24 -alkenyl, aryl-C 1 -C 24 -alkynyl, heteroaryl, heteroaryl-C 1 -C 24 -alkyl, heteroaryl-C 1 -C 24 -alkenyl, heteroaryl-C 1 -C 24 -alkynyl, sulfonate, arylsulfonate, and heteroarylsulfonate;
wherein the “A” moiety and the “Z” moiety are different from one another;
wherein only one of A and Z is bound to the first polymer matrix;
wherein “m” is an integer of from 2 to 8 and “n” is an integer equal to or greater than 100; and
a second polymer matrix that interpenetrates with the first polymer matrix.
2. The hydrogel of claim 1 , further comprising a pharmacologically-active agent covalently bonded to one of the “A” or “Z” moieties that is not bonded to the first polymer matrix.
3. The hydrogel of claim 1 , where the first polymer matrix is proteinaceous.
4. The hydrogel of claim 1 , wherein the first polymer matrix is selected from the group consisting of gelatin, calcium alginate, calcium/sodium alginate, collagen, oxidized regenerated cellulose, carboxymethylcellulose, amino-modified cellulose, and whey protein.
5. The hydrogel of claim 1 , wherein the first polymer matrix is selected from the group consisting of gelatin and collagen.
6. The hydrogel of claim 1 , wherein the first polymer matrix is cross-linked with a cross-linking reagent.
7. The hydrogel of claim 1 , wherein the first polymer matrix is cross-linked with glutaraldehyde.
8. The hydrogel of claim 1 , wherein the first polymer matrix further comprises EDTAD moieties bonded to it.
9. The hydrogel of claim 1 , wherein “n” is equal to or greater than 200.
10. The hydrogel of claim 1 , wherein “n” is equal to or greater than 2,000.
11. The hydrogel of claim 1 , wherein “n” is equal to or greater than 20,000.
12. The hydrogel of claim 1 , further comprising a pharmacologically-active agent entrained within the hydrogel.
13. The hydrogel of claim 1 , further comprising living cells entrained within the hydrogel.
14. The hydrogen of claim 2 , wherein the pharmacologically active agent is selected from the group consisting of vulnerary agents, hemostatic agents, antibiotics, antithelmintics, antifungal agents, hormones, anti-inflammatory agents, proteins, polypeptides, oligonucleotides, cytokines, and enzymes.
15. The hydrogel of claim 14 , wherein the pharmacologically active agent is a vulnerary agent.
16. The hydrogel of claim 12 , wherein the pharmacologically active agent is selected from the group consisting of vulnerary agents, hemostatic agents, antibiotics, antithelmintics antifungal agents, hormones, anti-inflammatory agents, proteins, polypeptides, oligonucleotides, cytokines, and enzymes.
17. The hydrogel of claim 16 , wherein the pharmacologically active agent is a vulnerary agent.